Bio-Rad

Dual‑Targeting Breakthroughs: Advancements in Bispecific Antibody Development

Download this complimentary Expert Insights eBook today!

Bio-Rad Acquires Stilla Technologies

Bio-Rad Laboratories, a life science research and clinical diagnostics company, has completed the acquisition of Stilla Technologies, a developer of digital PCR (dPCR) systems.

Top-Feature

Agilent Technologies Inc.

Comprehensive Insights into Antibody–Drug Conjugates (ADC) for Precision Cancer Therapy

Aenova Holding GmbH

Small Molecules: Choosing a Strategic, Scalable, and De-Risked Development Path

CHEManager c/o Wiley-VCH Verlag

German Biotech Days 2026: Biotechnology as The Key to Industrial Competitiveness

Special Issue

Explore the Future of Plastics

This special CHEManager issue explores the industry’s pivotal shift towards a more sustainable, circular plastics value chain. Readers will find expert analysis and real-world solutions for today’s most pressing recycling and regulatory challenges.

Bio-Rad Laboratories

Bio-Rad

Dual‑Targeting Breakthroughs: Advancements in Bispecific Antibody Development

Bio-Rad Acquires Stilla Technologies

Top-Feature

Comprehensive Insights into Antibody–Drug Conjugates (ADC) for Precision Cancer Therapy

Small Molecules: Choosing a Strategic, Scalable, and De-Risked Development Path

Upcoming Virtual Events

German Biotech Days 2026: Biotechnology as The Key to Industrial Competitiveness

Special Issue

Circular Plastics Economy

Bio-Rad

Dual‑Targeting Breakthroughs: Advancements in Bispecific Antibody Development

Bio-Rad Acquires Stilla Technologies

Top-Feature

Comprehensive Insights into Antibody–Drug Conjugates (ADC) for Precision Cancer Therapy

Small Molecules: Choosing a Strategic, Scalable, and De-Risked Development Path

Upcoming Virtual Events

German Biotech Days 2026: Biotechnology as The Key to Industrial Competitiveness

Special Issue

Circular Plastics Economy

Newsletter & e-edition